Table 2 Clinical and demographic data.

SP, secondary progressive MS; RR, relapsing-remitting MS; na, not available.

PatientDosage*Age
(years)
SexMS typeDisease duration
(years)
Relapse
12/24 mo
MRIEDSSHLA DR15
T1 Gd+T2
inims-011 × 10349FSP50/10103.5Positive
inims-021 × 10539FRR51/10121.5Negative
inims-031 × 10727FRR21/2121Negative
inims-041 × 10842FRR20/1041.5Negative
inims-055 × 10844FRR160/0084Negative
inims-061 × 10943FSP130/00274.5Negative
inims-071 × 10934FRR1.54/na0361.5Positive
inims-082.5 × 10942FRR3.52/41231.5Positive
inims-103 × 10942MRR2.51/11402Negative

*Absolute number of antigen-coupled cells infused.

†Number of relapses in the previous 12/24 months.

‡Number of lesions on brain MRI.